CA3010977A1 - Novel cross protective vaccine compositions for porcine epidemic diarrhea virus - Google Patents
Novel cross protective vaccine compositions for porcine epidemic diarrhea virus Download PDFInfo
- Publication number
- CA3010977A1 CA3010977A1 CA3010977A CA3010977A CA3010977A1 CA 3010977 A1 CA3010977 A1 CA 3010977A1 CA 3010977 A CA3010977 A CA 3010977A CA 3010977 A CA3010977 A CA 3010977A CA 3010977 A1 CA3010977 A1 CA 3010977A1
- Authority
- CA
- Canada
- Prior art keywords
- vaccine compositions
- epidemic diarrhea
- porcine epidemic
- diarrhea virus
- cross protective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20061—Methods of inactivation or attenuation
- C12N2770/20064—Methods of inactivation or attenuation by serial passage
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention is directed to novel isolates of porcine epidemic diarrhea virus (PEDV) and vaccine compositions made therefrom. The vaccine compositions protect swine from PED disease, and are cross protective against a wide variety of strains, whether variant or prototype, that currently circulate throughout the world. The vaccines are provided in both killed and live virus forms, as derived from strain Calaf14, and suggest specific amino acid modifications to the encoding sequences of all other PEDV strains that may improve their performance as vaccines.. Novel culture methods are also employed to increase reproducible yield of cultured viruses.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2016/012899 WO2017123201A1 (en) | 2016-01-11 | 2016-01-11 | Novel cross protective vaccine compositions for porcine epidemic diarrhea virus |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3010977A1 true CA3010977A1 (en) | 2017-07-20 |
Family
ID=55358111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3010977A Abandoned CA3010977A1 (en) | 2016-01-11 | 2016-01-11 | Novel cross protective vaccine compositions for porcine epidemic diarrhea virus |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3402878A1 (en) |
CA (1) | CA3010977A1 (en) |
WO (1) | WO2017123201A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108060139B (en) * | 2017-08-31 | 2021-07-20 | 浙江美保龙生物技术有限公司 | Isolation culture method of porcine epidemic diarrhea virus |
CN107446894A (en) * | 2017-09-15 | 2017-12-08 | 天津瑞普生物技术股份有限公司 | A kind of Porcine epidemic diarrhea virus preparation method |
KR20210062015A (en) * | 2018-09-20 | 2021-05-28 | 베링거잉겔하임베트메디카게엠베하 | Modified PEDV Spike Protein |
CN110894216B (en) * | 2019-11-21 | 2022-03-08 | 河北农业大学 | Porcine epidemic diarrhea virus epitope peptide, monoclonal antibody and application |
CN114438040A (en) * | 2020-11-04 | 2022-05-06 | 中山大学 | Monoclonal cell strain secreting antibody with PEDV (porcine epidemic diarrhea Virus) neutralizing activity and application thereof |
CN115074334B (en) * | 2021-03-15 | 2024-01-19 | 夏津新希望六和农牧有限公司 | Porcine epidemic diarrhea virus strain, amplification culture method, vaccine composition prepared from porcine epidemic diarrhea virus strain, preparation method and application of porcine epidemic diarrhea virus strain and amplification culture method |
CN114931648B (en) * | 2022-06-15 | 2024-02-27 | 金宇保灵生物药品有限公司 | Heat-resistant protective agent for combined live vaccine against porcine epidemic diarrhea and transmissible gastroenteritis, and preparation method and application thereof |
CN117286162B (en) * | 2023-04-14 | 2024-08-23 | 扬州大学 | Recombinant porcine delta coronavirus infectious clone and construction method and application thereof |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
WO1993013302A1 (en) | 1991-12-23 | 1993-07-08 | Michael Zoche | Engine with oil separator |
US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
AU729579B2 (en) | 1996-10-23 | 2001-02-01 | Trustees Of The University Of Pennsylvania, The | Immunotherapy and improved vaccines |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
MXPA00008352A (en) | 1998-02-27 | 2002-10-17 | Univ Pennsylvania | Vaccines, immunotherapeutics and methods for using the same. |
AU770333B2 (en) | 1998-09-30 | 2004-02-19 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Mutant cholera holotoxin as an adjuvant |
AU769539B2 (en) | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
JP2004535187A (en) | 2001-06-07 | 2004-11-25 | ワイス・ホールデイングス・コーポレーシヨン | Mutant forms of cholera holotoxin as adjuvants |
KR100877258B1 (en) | 2001-06-07 | 2009-01-12 | 와이어쓰 홀딩스 코포레이션 | Mutant forms of cholera holotoxin as an adjuvant |
PL216541B1 (en) | 2002-08-26 | 2014-04-30 | Pfizer Prod Inc | Vaccine for respiratory and reproductive system infections in cattle |
KR100502008B1 (en) | 2003-04-29 | 2005-07-18 | 녹십자수의약품(주) | A attenuated porcine epidemic diarrhrea virus, an immunogenic composition comprising the same and a method for detecting the virus |
HUE028921T2 (en) | 2008-06-27 | 2017-01-30 | Zoetis Services Llc | Novel adjuvant compositions |
CN104152578B (en) * | 2013-06-03 | 2016-03-30 | 中国农业科学院上海兽医研究所 | Porcine epidemic diarrhea virus RT-PCR differential diagnosis kit and application thereof |
EP3046580A2 (en) | 2013-09-19 | 2016-07-27 | Zoetis Services LLC | Oil-based adjuvants |
RS62414B1 (en) * | 2014-07-11 | 2021-10-29 | Zoetis Services Llc | Novel vaccine compositions for porcine epidemic diarrhea virus |
-
2016
- 2016-01-11 EP EP16704501.2A patent/EP3402878A1/en not_active Withdrawn
- 2016-01-11 WO PCT/US2016/012899 patent/WO2017123201A1/en active Application Filing
- 2016-01-11 CA CA3010977A patent/CA3010977A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2017123201A1 (en) | 2017-07-20 |
EP3402878A1 (en) | 2018-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3010977A1 (en) | Novel cross protective vaccine compositions for porcine epidemic diarrhea virus | |
WO2016007576A3 (en) | Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus | |
JP2017035093A5 (en) | ||
HRP20171213T1 (en) | RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs) | |
CO2018005229A2 (en) | Respiratory Syncytial Virus Vaccine | |
IL276210B2 (en) | Mers-cov vaccine | |
MY163972A (en) | Attenuated recombinant newcastle disease virus and vaccine containing the same | |
EP4043031A3 (en) | Zika viral antigen constructs | |
WO2007095318A3 (en) | Influenza antigens, vaccine compositions, and related methods | |
EA201590304A1 (en) | VACCINE OF THE RECOMBINANT MODIFIED VIRUS OF ANPARA OSPOVAKCINA RESPIRATORY SYNCYIAL VIRUS | |
PH12019500592A1 (en) | New swine influenza vaccine | |
WO2011106607A3 (en) | Subunit vaccines for herpes viruses and methods of use | |
EA201991041A1 (en) | VACCINE AGAINST PORK PARVOVIRUS AND PIG REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND METHODS FOR ITS PRODUCTION | |
EA201291373A1 (en) | VACCINE AND METHODS TO ELIMINATE INFECTION CAUSED BY CAMPYLOBACTER | |
WO2013001285A3 (en) | Fmdv vp1 peptides | |
RU2018116601A (en) | Immunogenic Fusion Protein | |
PH12017500216B1 (en) | Vaccine in serotype-9 fowl adenovirus recombinant vector | |
WO2016141338A3 (en) | Marker system, in particular for baculovirus-expressed subunit antigens | |
PH12018501750A1 (en) | Porcine reproductive and respiratory syndrome vaccine virus | |
HRP20211838T1 (en) | Truncated rotavirus vp4 protein and application thereof | |
MX339731B (en) | Infectious bronchitis vaccines derived from ib-qx-like strains. | |
AR097029A1 (en) | ACCELERATION OF THE IMMUNE RESPONSE INDUCED BY VECTOR VIRUS IN BIRDS, COMPOSITION, USE, VACCINATION METHOD AND METHOD FOR ACCELERATING THE IMMUNE RESPONSE | |
NZ704188A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
MX2019007924A (en) | Influenza vaccines. | |
RU2013133856A (en) | VACCINES WITH LIVING BACTERIAL ISOLATES FOR SYSTEM INTRODUCTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20180710 |
|
FZDE | Dead |
Effective date: 20201112 |